Giovannoni G, et al. Cladribine tablets in high disease activity (HDA) subgroups from the CLARITY study of patients with relapsing multiple sclerosis (RMS). EP1157. EAN 2017.
Podcast: AI in stroke - Using deep learning to predict clinical outcomes after stroke
jan 2024 | Neuro-vasculair